 0 Table of Contents |
  1 Overview |
  2 Artifacts Summary |
   2.1 HtmlElementLink |
   2.2 HtmlElementLinkV3 |
   2.3 Lenses |
   2.4 DLCategoryVS |
   2.5 PDcategoryVS |
   2.6 PDtypeVS |
   2.7 Category of EPI |
   2.8 Example ICPC2 CS |
   2.9 Persona Vector Dimensions categories |
   2.10 Persona Vector Dimensions Code |
   2.11 Questionnaire example Dimensions |
   2.12 0818 create organization |
   2.13 28 tablets in bottle |
   2.14 Add title here |
   2.15 Administrable Product - Herceptin (trastazumab) 150 mg for Intravenous Use |
   2.16 Administrable Product - simvastatin 20 mg tablet |
   2.17 Administrable Product - Tegretol (carbamazepine) 200 mg for tablet |
   2.18 BeneFIX SmPC Belgium |
   2.19 BenefiX SmPC Bundle |
   2.20 binaryimage0014 |
   2.21 binaryimage003 |
   2.22 binaryimage003-1537998405 |
   2.23 binaryimage004 |
   2.24 binaryimage004-124372563 |
   2.25 binaryimage006 |
   2.26 binaryimage006-1085115419 |
   2.27 binaryimage007 |
   2.28 binaryimage007-1887834135 |
   2.29 binaryimage008 |
   2.30 binaryimage008-1358253692 |
   2.31 binaryimage010 |
   2.32 binaryimage010-240412440 |
   2.33 binaryimage012-1035983834 |
   2.34 binaryimage012-251481591 |
   2.35 binaryimage012a |
   2.36 binaryimage012b |
   2.37 binaryimage013 |
   2.38 binaryimage013-244659630 |
   2.39 binaryimage014-39753133 |
   2.40 binaryimage016-646543884 |
   2.41 binarypfizerlogo |
   2.42 Bundle for Enbrel 25mg PFS - Jordanian AR Package Leaflet |
   2.43 Bundle for Enbrel 25mg PFS - Jordanian EN Package Leaflet |
   2.44 Bundle for Enbrel 50mg PFP - Jordanian AR Package Leaflet |
   2.45 Bundle for Enbrel 50mg PFP - Jordanian EN Package Leaflet |
   2.46 Bundle for Enbrel 50mg PFS - Jordanian AR Package Leaflet |
   2.47 Bundle for Enbrel 50mg PFS - Jordanian EN Package Leaflet |
   2.48 Bundle for Genotropin 5.0/5.3/12 mg powder and solvent - AR Jordanian Package Leaflet |
   2.49 Bundle for Genotropin 5.0/5.3/12 mg powder and solvent - EN Jordanian Package Leaflet |
   2.50 bundle for prevenar |
   2.51 Bundle for zithromax (azithromycin) 250 mg capsules - Jordanian AR Package Leaflet |
   2.52 Bundle for zithromax (azithromycin) 250 mg capsules - Jordanian EN Package Leaflet |
   2.53 Bundle for zithromax (azithromycin) POS - Jordanian AR Package Leaflet |
   2.54 Bundle for zithromax (azithromycin) POS - Jordanian EN Package Leaflet |
   2.55 Bundle Japan JA - Package Insert for Herceptin (trastazumab) 150 mg for Intravenous Use |
   2.56 Bundle Japan JA - Package Insert for Simvastatin 20 mg tablets |
   2.57 Bundle Japan JA - Package Insert for Tegretol (carbamazepine) 200 mg for tablet |
   2.58 Bundle Jordan AR - Package Leaflet for zithromax (azithromycin) 250 mg capsules - zithromax (azithromycin) 250 mg capsules |
   2.59 Bundle Jordan AR - Patient Information for Talzenna 0.25 mg, 1 mg capsules |
   2.60 Bundle Jordan AR - Patient Medication Information for Xyntha® Lyophilized Powder for Reconstitution in a Vial |
   2.61 Bundle Jordan EN - Product Monograph for Xyntha® Lyophilized Powder for Reconstitution in a Vial |
   2.62 Bundle PLD Palbociclib |
   2.63 Bundle PLD Palbociclib Ibrance MYS Malay |
   2.64 carnubawax |
   2.65 CLDTemplate |
   2.66 Composition - Patient Medicination Information : Xyntha® Lyophilized Powder for Reconstitution in a Vial |
   2.67 Composition - Product Monograph for Package leaflet: Xyntha® Lyophilized Powder for Reconstitution in a Vial |
   2.68 Composition for Package leaflet: Arab Gulf and Jordan Talzenna 0.25 mg, 1 mg capsules |
   2.69 Composition PLD Palbociclib Ibrance MYS Malay |
   2.70 crystallinecellulose |
   2.71 ePI document Bundle for zithromax (azithromycin) 250 mg capsules - Jordanian Package Leaflet |
   2.72 Herceptin (trastazumab) Package Leaflet - 150 mg for Intravenous Use |
   2.73 hypromelose |
   2.74 Ibrance CLD Composition English |
   2.75 Ibrance CLD MYS Bundle English |
   2.76 Ibrance MAH |
   2.77 Ingredient - carbamazepine |
   2.78 Ingredient - simvastatin |
   2.79 Ingredient - trastazumab |
   2.80 lightanhydroussilicicacid |
   2.81 magnesiumcarbonate |
   2.82 magnesiumstearate |
   2.83 manitemcarbamazepine200 |
   2.84 manitemherceptin150 |
   2.85 manitemsimvastatin20 |
   2.86 mannitol |
   2.87 Manufactured, Packaged and Released By Wyeth Farma S.A |
   2.88 Marketing authorisation holder - Pfizer Canada ULC. |
   2.89 Marketing Authorization Holder - Chugai Pharmaceutical Co., Ltd. |
   2.90 Marketing Authorization Holder - Fujinaga Pharmaceutical Co., Ltd. |
   2.91 Marketing Authorization Holder - Ohara Pharmaceutical Co., Ltd. |
   2.92 Master Gulf and Levant- Prevenar 13 0.5 ml- PLD Jordan |
   2.93 Medicinal Product - Herceptin (trastazumab) 150 mg for Intravenous Use |
   2.94 Medicinal Product - Simvastatin 20 mg tablets |
   2.95 Medicinal Product - Tegretol (carbamazepine) 200 mg for tablet |
   2.96 Medicinal Product Enbrel 25mg PFS |
   2.97 Medicinal Product Enbrel 25mg PFS |
   2.98 Medicinal Product Enbrel 50mg PFP |
   2.99 Medicinal Product Enbrel 50mg PFP |
   2.100 Medicinal Product Enbrel 50mg PFS |
   2.101 Medicinal Product Enbrel 50mg PFS |
   2.102 Medicinal Product Genotropin 5.0/5.3/12 mg powder and solvent |
   2.103 Medicinal Product Genotropin 5.0/5.3/12 mg powder and solvent |
   2.104 Medicinal Product zithromax (azithromycin) 250 mg capsules |
   2.105 Medicinal Product zithromax (azithromycin) 250 mg capsules |
   2.106 Medicinal Product zithromax (azithromycin) 250 mg capsules - النشرة الداخلية: معلومات للمريض - كبسولات زيثروماكس® 250 مجم |
   2.107 Medicinal Product zithromax (azithromycin) 250 mg capsules - AR |
   2.108 Medicinal Product zithromax (azithromycin) POS |
   2.109 Medicinal Product zithromax (azithromycin) POS |
   2.110 methylparaben |
   2.111 org for Master Gulf and Levant- Prevenar 13--0.5 ml- PLD Jordan |
   2.112 Organization PLD Palbociclib Ibrance MYS Malay |
   2.113 Organization_PLD_Palbociclib |
   2.114 Package Leaflet - simvastatin 20 mg tablets |
   2.115 packherceptinvial |
   2.116 packsimvastatin20 |
   2.117 Pfizer Europe MA EEIG |
   2.118 Pfizer Europe MA EEIG, Boulevard de la Plaine 17, 1050 Bruxelles, Belgium |
   2.119 Pfizer Europe MA EEIG, Boulevard de la Plaine 17, 1050 Bruxelles, Belgium |
   2.120 Pfizer Europe MA EEIG, Boulevard de la Plaine 17, 1050 Bruxelles, Belgium |
   2.121 Pfizer Europe MA EEIG, Boulevard de la Plaine 17, 1050 Bruxelles, Belgium |
   2.122 Pfizer Europe MA EEIG, Boulevard de la Plaine 17, 1050 Bruxelles, Belgium |
   2.123 Pfizer Europe MA EEIG, Boulevard de la Plaine 17, 1050 Bruxelles, Belgium |
   2.124 Pfizer Limited as Marketing authorisation holder |
   2.125 Pfizer Limited as Marketing authorisation holder |
   2.126 Pfizer Limited as Marketing authorisation holder |
   2.127 Pfizer Limited as Marketing authorisation holder |
   2.128 Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom |
   2.129 Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom |
   2.130 Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom |
   2.131 Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom |
   2.132 Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom |
   2.133 Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom - AR |
   2.134 Pfizer SA, Boulevard de la Plaine 17, 1050 Bruxelles, Belgium |
   2.135 Pfizer SA, Boulevard de la Plaine 17, 1050 Bruxelles, Belgium |
   2.136 PLD Palbociclib - Ibrance MYS English |
   2.137 polyethyleneglycol |
   2.138 polysorbate |
   2.139 polyvinylalcohol |
   2.140 Regulated Authorization - Herceptin (trastazumab) 150 mg for Intravenous Use |
   2.141 Regulated Authorization - Herceptin (trastazumab) 150 mg for Intravenous Use |
   2.142 Regulated Authorization - Tegretol (carbamazepine) 200 mg for tablet |
   2.143 silicondioxide |
   2.144 SmPCtemplate |
   2.145 sodiumstarch |
   2.146 Substance - simvastatin |
   2.147 Substance - trastazumab |
   2.148 Substance - trastazumab |
   2.149 sucrose |
   2.150 syntehticwax |
   2.151 talc |
   2.152 Tegretol (carbamazepine) 200 mg for tablet |
   2.153 Template of Bundle |
   2.154 Template of CLD Bundle |
   2.155 Template of organization |
   2.156 Test for compostion template |
   2.157 titaniumdioxide2 |
   2.158 TSZ 0817 Organization creation |
   2.159 TSZ 0818 Bundle UK EN - PIL Talzenna |
   2.160 TSZ 0818TestandLearn Composition |
   2.161 Master Gulf Levant _LL-PLD_ Aromasin(Exemestane)_ 25mg_ tablets- AR (Bundle) |
   2.162 Master Gulf & Levant - Braftovi - 50, 75 mg Capsule - AR (Bundle) |
   2.163 Master Gulf & Levant - Braftovi - 50, 75 mg Capsule - EN (Bundle) |
   2.164 Inlyta - 1mg, 5 mg Film coated tablets - AR (Bundle) |
   2.165 Inlyta - 1mg, 5 mg Film coated tablets - EN (Bundle) |
   2.166 Master Gulf Levant - Aromasin 25mg - tablets - PLD Jordan (Bundle) |
   2.167 Master Gulf & Levant - Rapamun -tablets - 05 1 2 mg - AR (Bundle) |
   2.168 Master Gulf & Levant - Rapamun -tablets - 05 1 2 mg - EN (Bundle) |
   2.169 Talzenna® (talazoparib) 0.25 mg and 1 mg hard capsules (Bundle) |
   2.170 Vfend(Voriconazole)50 mg 200 mg film-coated tablets - EN (Bundle) |
   2.171 Vfend(Voriconazole)50 mg 200 mg film-coated tablets - AR (Bundle) |
   2.172 Enbrel® (etanercept) 50 mg/ml solution for subcutaneous injection (Bundle) |
   2.173 Talzenna® (talazoparib) 0.1 mg, 0.25 mg and 1 mg hard capsules (Bundle) |